Practical Management of Adult Ultra-Rare Primary Retroperitoneal Soft Tissue Sarcoma: A Focus on Perivascular Epithelioid Tumours and Extraosseous Ewing Sarcoma
Current Oncology · 21.06.2023 · 30 (7) · 5953-5972
DOI: 10.3390/curroncol30070445 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 21.06.2023. Verfasst von Sameer S Apte und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Sarcoma, Retroperitoneal Neoplasms, Soft Tissue Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
With the exception of well-differentiated liposarcoma, dedifferentiated liposarcoma, leiomyosarcoma, solitary fibrous tumour, malignant peripheral nerve sheath tumour, and undifferentiated pleomorphic sarcoma, the majority of the ≈70 histologic subtypes of retroperitoneal sarcoma are defined as ‘ultra-rare’ sarcomas, with an incidence of ≤1–5/1,000,000 persons/year. For most of these ultra-rare RPS subtypes, diagnosis and treatment follows international guidelines for the management of more common RPS histologies, with en bloc surgical resection as the mainstay of curative treatment, and enrolment in clinical trials where possible. Because the treatment of RPS is heavily driven by histology, the surgeon must be familiar with specific issues related to the diagnosis and management of ultra-rare sarcoma subtypes. Expert radiological and surgeon reviews are required to differentiate similarly presenting tumours where surgery can be avoided (e.g., angiomyolipoma), or where upfront systemic therapy is indicated (e.g., extraosseous Ewing’s sarcoma). Thus, the management of all retroperitoneal sarcomas should occur at a sarcoma referral centre, with a multidisciplinary team of experts dedicated to the surgical and medical management of these rare tumours. In this focused review, we highlight how diagnosis and management of the ultra-rare primary RPS histologies of malignant perivascular epithelioid cell tumour (PEComa), extraosseous Ewing sarcoma (EES), extraosseous osteosarcoma (EOS), and rhabdomyosarcoma (RMS) critically diverge from the management of more common RPS subtypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
- Division of General Surgery, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
- Division of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
ORCID-Profile: Sameer S Apte, Eyal Mor, Catherine Mitchell
Zitieren
APA
Apte, S. S., Mor, E., Mitchell, C., & Gyorki, D. E. (2023). Practical Management of Adult Ultra-Rare Primary Retroperitoneal Soft Tissue Sarcoma: A Focus on Perivascular Epithelioid Tumours and Extraosseous Ewing Sarcoma. Current Oncology, 30(7), 5953-5972. https://doi.org/10.3390/curroncol30070445
Vancouver
Apte SS, Mor E, Mitchell C, Gyorki DE. Practical Management of Adult Ultra-Rare Primary Retroperitoneal Soft Tissue Sarcoma: A Focus on Perivascular Epithelioid Tumours and Extraosseous Ewing Sarcoma. Current Oncology. 2023;30(7):5953-5972. doi:10.3390/curroncol30070445
BibTeX
@article{Apte2023,
author = {Apte, Sameer S and Mor, Eyal and Mitchell, Catherine and Gyorki, David E},
title = {Practical Management of Adult Ultra-Rare Primary Retroperitoneal Soft Tissue Sarcoma: A Focus on Perivascular Epithelioid Tumours and Extraosseous Ewing Sarcoma},
journal = {Current Oncology},
year = {2023},
volume = {30},
number = {7},
pages = {5953--5972},
doi = {10.3390/curroncol30070445}
}
EUVIMED